Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
intraflagellar transport 43 | 0.617 | 0.577 | 1.8E-11 |
|
disease | 0.300 | None | 1.000 | 4 | 0 | 2011 | 2018 | ||||||||
|
protocadherin 12 | 0.722 | 0.346 | 2.9E-13 |
|
group | 0.300 | None | 1.000 | 4 | 0 | 2008 | 2019 | ||||||||
|
ubiquinol-cytochrome c reductase binding protein | 0.736 | 0.308 | 1.6E-02 |
|
disease | 0.300 | None | 1.000 | 4 | 0 | 2003 | 2017 | ||||||||
|
protein phosphatase 1 regulatory subunit 13 like | 0.539 | 0.692 | 3.2E-02 |
|
phenotype | 0.300 | strong | 1.000 | 3 | 0 | 2005 | 2015 | ||||||||
|
protein phosphatase 1 regulatory subunit 13 like | 0.539 | 0.692 | 3.2E-02 |
|
disease | 0.300 | strong | 1.000 | 3 | 0 | 2005 | 2015 | ||||||||
|
ER lipid raft associated 2 | 0.647 | 0.500 | 6.7E-04 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 2012 | 2017 | ||||||||
|
lysosomal trafficking regulator | 0.621 | 0.692 | 1.5E-02 |
|
disease | 0.300 | strong | 1.000 | 3 | 0 | 2002 | 2014 | ||||||||
|
lysosomal trafficking regulator | 0.621 | 0.692 | 1.5E-02 |
|
group | 0.300 | strong | 1.000 | 3 | 0 | 2002 | 2014 | ||||||||
|
chloride voltage-gated channel Kb | 0.593 | 0.692 | 1.4E-22 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 2006 | 2013 | ||||||||
|
FA complementation group C | 0.507 | 0.808 | 2.8E-13 |
|
phenotype | 0.300 | strong | 1.000 | 3 | 0 | 1992 | 2016 | ||||||||
|
FA complementation group G | 0.556 | 0.769 | 2.5E-14 |
|
phenotype | 0.300 | strong | 1.000 | 3 | 0 | 1998 | 2017 | ||||||||
|
aldolase, fructose-bisphosphate A | 0.631 | 0.615 | 1.3E-03 |
|
group | 0.300 | strong | 1.000 | 3 | 0 | 1981 | 2016 | ||||||||
|
glutamate receptor interacting protein 1 | 0.581 | 0.769 | 0.51 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 2006 | 2014 | ||||||||
|
Tctex1 domain containing 2 | 0.751 | 0.346 | 3.2E-04 |
|
disease | 0.300 | strong | 1.000 | 3 | 0 | 2015 | 2017 | ||||||||
|
C2 domain containing 3 centriole elongation regulator | 0.636 | 0.538 | 4.4E-19 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 2014 | 2016 | ||||||||
|
glutaredoxin 5 | 0.659 | 0.538 | 0.75 |
|
disease | 0.300 | strong | 1.000 | 3 | 0 | 2007 | 2016 | ||||||||
|
dishevelled binding antagonist of beta catenin 1 | 0.547 | 0.692 | 0.40 |
|
disease | 0.300 | limited | 1.000 | 3 | 0 | 2009 | 2017 | ||||||||
|
transcobalamin 2 | 0.578 | 0.615 | 1.0E-06 |
|
disease | 0.300 | strong | 1.000 | 3 | 0 | 1999 | 2009 | ||||||||
|
transcobalamin 2 | 0.578 | 0.615 | 1.0E-06 |
|
disease | 0.300 | strong | 1.000 | 3 | 0 | 1999 | 2009 | ||||||||
|
transcobalamin 2 | 0.578 | 0.615 | 1.0E-06 |
|
disease | 0.300 | strong | 1.000 | 3 | 0 | 1999 | 2009 | ||||||||
|
centrosome and spindle pole associated protein 1 | 0.544 | 0.769 | 3.3E-29 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 2014 | 2014 | ||||||||
|
ADP ribosylation factor like GTPase 6 | 0.636 | 0.462 | 1.0E-02 |
|
disease | 0.300 | None | 1.000 | 3 | 0 | 2004 | 2009 | ||||||||
|
AKT serine/threonine kinase 3 | 0.512 | 0.808 | 1.00 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2012 | 2012 | ||||||||
|
NIPA magnesium transporter 1 | 0.682 | 0.462 | 5.9E-03 |
|
disease | 0.300 | None | 1.000 | 2 | 0 | 2003 | 2005 | ||||||||
|
collagen type V alpha 2 chain | 0.568 | 0.731 | 1.00 |
|
disease | 0.300 | strong | 1.000 | 2 | 0 | 2017 | 2018 |